Dawn L. Harmon

885 total citations
9 papers, 690 citations indexed

About

Dawn L. Harmon is a scholar working on Surgery, Rheumatology and Oncology. According to data from OpenAlex, Dawn L. Harmon has authored 9 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Rheumatology and 2 papers in Oncology. Recurrent topics in Dawn L. Harmon's work include Folate and B Vitamins Research (5 papers), Esophageal and GI Pathology (4 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Dawn L. Harmon is often cited by papers focused on Folate and B Vitamins Research (5 papers), Esophageal and GI Pathology (4 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Dawn L. Harmon collaborates with scholars based in Ireland, United Kingdom and United States. Dawn L. Harmon's co-authors include Alexander S. Whitehead, Jayne V. Woodside, Dorothy McMaster, Ian Young, J. W. G. Yarnell, Denis C. Shields, A. E. Evans, E. McCrum, K.F. Gey and Kun Peng and has published in prestigious journals such as The Journal of Immunology, Arteriosclerosis Thrombosis and Vascular Biology and Atherosclerosis.

In The Last Decade

Dawn L. Harmon

9 papers receiving 665 citations

Peers

Countries citing papers authored by Dawn L. Harmon

Since Specialization

Citations

This map shows the geographic impact of Dawn L. Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn L. Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn L. Harmon more than expected).

Fields of papers citing papers by Dawn L. Harmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn L. Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn L. Harmon. The network helps show where Dawn L. Harmon may publish in the future.

Co-authorship network of co-authors of Dawn L. Harmon

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn L. Harmon. A scholar is included among the top collaborators of Dawn L. Harmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn L. Harmon. Dawn L. Harmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Association of NOD2 with Crohn's Disease in a homogenous Irish population 2003 ·European Journal of Human Genetics ·(unknown), Dawn L. Harmon, Annie M. Curtis, (unknown), Clare O’Leary, Michelle Gardner, (unknown), Pat Vaughan, Denise Keegan, Colm O’Morain, Diarmuid O’Donoghue, Fergus Shanahan, Nollaig A. Parfrey, Kathleen A. Quane	65
2	Community-living nonagenarians in Northern Ireland have lower plasma homocysteine but similar methylenetetrahydrofolate reductase thermolabile genotype prevalence compared to 70–89-year-old subjects 2000 ·Atherosclerosis ·Irene Maeve Rea, Dorothy McMaster, Jayne V. Woodside, Ian Young, G P R Archbold, (unknown), (unknown), Helene McNulty, Dawn L. Harmon, Alexander S. Whitehead	28
3	Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations 1999 ·Genetic Epidemiology ·Dawn L. Harmon, Denis C. Shields, Jayne V. Woodside, Dorothy McMaster, J. W. G. Yarnell, Ian Young, Kun Peng, Barry Shane, Alun E. Evans, Alexander S. Whitehead	210
4	Genetic Analysis of the Thermolabile Variant of 5,10-Methylenetetrahydrofolate Reductase as a Risk Factor for Ischemic Stroke 1999 ·Arteriosclerosis Thrombosis and Vascular Biology ·Dawn L. Harmon, (unknown), R. Meleady, (unknown), Denis C. Shields, (unknown), Davis Coakley, Ian Graham, Alexander S. Whitehead	59
5	Localization of the Gene for Autosomal Recessive Congenital Hereditary Endothelial Dystrophy (CHED2) to Chromosome 20 by Homozygosity Mapping 1999 ·Genomics ·Collette K. Hand, Dawn L. Harmon, Susan Kennedy, (unknown), L. M. T. Collum, Nollaig A. Parfrey	47
6	A Common Genetic Variant Affecting Folate Metabolism is Not Over-Represented in Chronic Fatigue Syndrome 1997 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Dawn L. Harmon, Dorothy McMaster, (unknown), Denis C. Shields, Alexander S. Whitehead	1
7	The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia 1996 ·QJM ·Dawn L. Harmon, Jayne V. Woodside, J. W. G. Yarnell, Dorothy McMaster, Ian Young, E. McCrum, K.F. Gey, Alexander S. Whitehead, A. E. Evans	253
8	Evolution of hemopoietic ligands and their receptors. Influence of positive selection on correlated replacements throughout ligand and receptor proteins 1996 ·The Journal of Immunology ·Denis C. Shields, Dawn L. Harmon, Alexander S. Whitehead	8
9	The evolution of haematopoietic cytokine /receptor complexes 1995 ·Cytokine ·Denis C. Shields, Dawn L. Harmon, (unknown), Alexander S. Whitehead	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact